What is the current stock price of Primavera Capital Acquisition Corporation (PV)?

As of the latest market data, Primavera Capital Acquisition Corporation (PV) is trading at $9.90. The stock has seen a gain of 0.20% today.

Does Primavera Capital Acquisition Corporation (PV) pay a dividend?

Based on current data, Primavera Capital Acquisition Corporation does not have a confirmed active dividend policy.

What is the market cap of Primavera Capital Acquisition Corporation?

The current market capitalization of Primavera Capital Acquisition Corporation (PV) is approximately unavailable.

PV

Primavera Capital Acquisition Corporation·Financial Services

9.90

0.202%(+0.02)

Market Closed

Last Updated: — ET

52W L: $8.9652W H: $10.51

PV NEWS

businesswire.com

Mar 3

AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced its plans to expand the development of oral epetraborole into a Phase 2 proof-of-concept clinical study in adults with phlebotomy-dependent polycythemia vera (PV). PV is a blood cancer characterized by overproduction of red blood cells in the bone marrow. This overproduction.

Company Profile

Primavera Capital Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in consumer companies China. The company was incorporated in 2020 and is based in Central, Hong Kong.

Sector

Financial Services

Industry

Shell Companies

IPO Date

2021-03-15

Beta

0.00

Websitepvspac.com↗

PV

AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)

AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)

Westfuller Advisors, LLC Buys 2,132 Shares of T1 Energy Inc (TE)

Stone House Investment Management, LLC Buys 2,500 Shares of T1 Energy Inc (TE)